Syncona Portfolio Ltd

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 13, 2024), Syncona Portfolio Ltd reported 3 stock positions worth $85.9 million. Its top holding was Autolus Therapeutics (AUTL) at 86.5% of the portfolio, followed by Achilles Therapeutics PL-ADR (ACHL, 10.5%) and Century Therapeutics (IPSC, 3.0%). Compared with Q1 2024, it opened 1 new position. The biggest buy was a new position in Century Therapeutics (IPSC).

Most Recent 13F
Q2 2026
Location
St Peter Port, Guernsey, X0
CIK
0001725042
Portfolio Value
$85.9M (Q2 2024)
SEC Filing
0000950123-24-008200 ↗ filed Aug 13, 2024

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $150.1M Q1 2024 Q2 2024: $85.9M $85.9M Q2 2024 Q3 2024: $80.7M Q3 2024 Q4 2024: $53.0M Q4 2024 Q1 2025: $26.4M Q1 2025 Q2 2025: $38.6M Q2 2025 Q3 2025: $27.7M Q3 2025 Q4 2025: $34.3M Q4 2025 Q1 2026: $25.7M Q1 2026 Q2 2026: $26.6M Q2 2026

Holdings 3 stocks · $85.9M
AUTL Autolus Therapeutics PLC 86.51% 21,346,829 $74.3M No change
ACHL Achilles Therapeutics PL-ADR 10.52% 11,086,909 $9.0M No change
IPSC Century Therapeutics Inc. 2.97% 1,000,771 $2.6M New

Portfolio Sells Q1 2024 → Q2 2024
None this quarter.

Portfolio Buys Q1 2024 → Q2 2024
IPSC Century Therapeutics Inc. New 2.97% +2.97

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 1$26.6MAUTL
Q1 2026 2$25.7MAUTL, IPSC
Q4 2025 2$34.3MAUTL, IPSC
Q3 2025 2$27.7MAUTL, IPSC
Q2 2025 2$38.6MAUTL, IPSC
Q1 2025 2$26.4MAUTL, IPSC
Q4 2024 3$53.0MAUTL, ACHL, IPSC
Q3 2024 3$80.7MAUTL, ACHL, IPSC
Q2 2024 3$85.9MAUTL, ACHL, IPSC
Q1 2024 2$150.1MAUTL, ACHL